Elsevier

Atherosclerosis

Volume 235, Issue 1, July 2014, Pages 130-139
Atherosclerosis

Review
Vitamin D supplementation and lipid profile: What does the best available evidence show?

https://doi.org/10.1016/j.atherosclerosis.2014.04.024Get rights and content

Highlights

  • Controlled trials assessing the effects of vitamin D on serum lipids are presented.

  • Observational studies have found favorable lipid profiles with higher serum 25-OH D levels.

  • Interventional studies fail to support the findings of observational studies.

  • High serum vitamin D may not be the cause of good health but its outcome instead.

Abstract

Vitamin D supplements have increasingly been used for the treatment and prevention of osteoporosis. Historically, effects of the vitamin on the cardiovascular (CV) system have been proposed and demonstrated in the literature, including benefits on serum lipids. Although observational studies support an association between increased serum vitamin D levels and a favorable lipid profile, interventional studies have shown no effects.

This review presents and analyzes all the related randomized controlled trials (RCTs) identified in the literature from 1987 to present. A systematic literature search was conducted via MEDLINE, Cochrane Library and EMBASE and, out of 19 relevant RCTs identified, only one reported benefits of vitamin D supplementation on lipid profile parameters, while the rest showed no effects or even adverse outcomes, which are highlighted by the only meta-analysis in the field.

Attempts to explain the paradox of beneficial findings of observational studies versus discouraging results of interventional studies have been made and the most popular suggests that high serum vitamin D concentrations may not be the cause of good health but its outcome instead, as healthy people are more likely to stay outdoors longer and have better eating habits.

For definitive answers to be given, large, well-designed RCTs need to be conducted that will take into account and adjust for dietary consumption as well as serum calcium and parathyroid hormone levels, both of which have been shown to be associated with the CV system. Until then, recommendations for vitamin D supplementation should not change.

Introduction

Vitamin D has traditionally been associated with bone health and, together with calcium, is increasingly becoming popular for the prevention and treatment of osteoporosis. Recently, both calcium and vitamin D have been suggested to exert effects on the cardiovascular (CV) system, however the existing evidence is highly controversial. The effects of calcium on the CV system have been reviewed elsewhere and although findings of different studies are conflicting, calcium supplements should be prescribed with caution as significant adverse CV effects have been reported with high intake [1].

The determination of the presence and nature of effects of vitamin D on the CV system is particularly important for a number of reasons. Firstly, hypovitaminosis D is a global health problem with detrimental consequences and notably, according to a recent Workshop Consensus for Vitamin D Nutritional Guidelines, approximately 50% of the elderly population in North America and 60% in the rest of the world have insufficient levels of vitamin D, partly due to reduced outdoor activity, global dimming and decreases in the skin synthesis of vitamin D with age [2], [3]. Large proportions of younger populations also have unsatisfactory vitamin D concentrations. If the correlation between hypovitaminosis D and CV events that were recently reported by epidemiological pooled analysis of prospective studies is true, vitamin D supplementation will function dually both to neutralize inadequate vitamin D levels and the direct metabolic consequences and as a prevention tool of the number one cause of death, CV disease [2], [4], [5]. Conversely, should the evidence strongly suggest adverse effects of the vitamin on the CV system, its use will be restricted where possible and replaced by safer alternatives.

The present review specifically discusses the relationship between vitamin D and serum lipid profile, focusing on evidence deriving from all RCTs identified in the literature.

The vitamin D receptor (VDR) has been historically considered as the only means by which calcitriol achieves its functions, which were thought to be exclusively endocrine and related to mineral metabolism. The VDR initially couples with retinoic X receptor to form a heterodimer, which subsequently binds to vitamin D response elements in the promoter regions of target genes. Recent data, however, has shown that the VDR is expressed in a number of tissues leading to various effects such as immunomodulation and enhancement of cellular proliferation and differentiation. Interestingly, vitamin D regulates around 3% of the genome with numerous effects and functions. Finally, a cytoplasmic form of the VDR has also been identified that responds rapidly or non-genomically to calcitriol and is thought to be involved in cellular calcium handling and other processes [6], [7], [8].

The identification of VDR expression in endothelial cells, vascular smooth muscle cells and cardiac myocytes strongly reinforced the presence of a relation linking vitamin D and the CV system, without, however, implying the nature of this association. Potential effects have been proposed on factors including, but not limited to, blood pressure, serum lipids, CV events, CV death, cardiac work and cardiometabolic syndromes [8].

Although the major source of vitamin D is synthesis in the skin secondary to ultraviolet (UV) B irradiation, it can also be acquired through dietary consumption. Vitamin D may exist in the form of vitamin D2 (ergocalciferol), which derives from the UV irradiation of ergosterol (found in plants and fungi), or vitamin D3 (cholecalciferol) that is produced after UVB irradiation of 7-dehydrocholesterol in the skin of animals. Both are thought to be prohormones as they are biologically inactive and only after a two-step hydroxylation process in the liver and kidneys do they yield the active hormone 1,25-dihydroxyvitamin D (calcitriol). Synthetic supplements exist in both D2 and D3 forms and even though both are eventually converted to the biologically active metabolite, recent data suggested a difference in their efficacy in raising serum 25-OH D, which is the established marker of vitamin D status [9].

In fact, a large meta-analysis of RCTs indicated that vitamin D3 supplements may be more efficacious in elevating serum 25-OH D compared to vitamin D2 supplements, as a statistically significant difference was reported. The favoring of vitamin D3 was evident even with small daily doses and less frequent administration as a bolus at higher dosages [9].

Additionally, a Cochrane meta-analysis investigating the effects of vitamin D supplementation on all-cause mortality found that only vitamin D3 supplementation seems to decrease mortality, while vitamin D2, calcitriol and alfacalcidol had no statistically significant effect on mortality [10].

The exact reasons underlying this difference are still unclear, however these results must be taken seriously into consideration for the future manufacture and use of vitamin D supplements [9].

Each individual may be characterized as vitamin D deficient, insufficient or sufficient based on serum 25-OH D levels. The limit for deficiency is set at a value (20 ng/ml) below which PTH levels become suppressible when challenged with pharmacologic doses of vitamin D and sufficiency is above the value (30 ng/ml) where PTH levels reach their lowest and intestinal calcium absorption is at its maximum. Hence deficiency is <20 ng/ml, sufficiency >30 ng/ml and insufficiency in-between (21–29 ng/ml) [2]. In order for sufficient levels to be achieved, at least 1000 International Units (IU) of vitamin D2 or D3 are thought to be required daily in cases where sun exposure is either absent or inadequate (e.g. winter, sunscreen use) [2].

Section snippets

Vitamin D and CV events

Before discussing the potential CV effects of the vitamin, a concise section summarizing its reported association with CV events is worthwhile, as possible links with CV mortality and events may be more important than correlations to CV parameters. In overview, despite the existence of a few studies that report neutral findings, the protective properties of vitamin D in terms of CV events and all-cause mortality are evident in the literature [10], [11], [12], [13], [14], [15].

A prospective

Vitamin D and lipid profile – randomized controlled trials

Despite the promising data of the observational studies, RCTs fail to indicate a causal association between vitamin D consumption and a favorable lipid profile. Out of 19 RCTs found in the literature up to date, only 1 demonstrated beneficial effects of vitamin D supplementation on serum lipid levels, while, importantly, the only meta-analysis identified, reported statistically significant adverse outcomes in some parameters [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46]

Paradox

Even though the associations noted in observational studies are well established, a causal effect has not yet been proven and a paradox exists: promising findings of observational studies versus discouraging results of interventional studies.

Reasonable explanations have been suggested to provide an explanation to this discrepancy: insufficient activity is a known risk factor for unfavorable lipid profiles, therefore dyslipidemia may be the result of reduced outdoor activity; these people may

Vitamin D, calcium and PTH: which is to blame?

Whenever either of the three is studied, at least a brief mention of the other two should be ideally made. Vitamin D, being one of the calcitropic hormones, is closely related to calcium as well as parathyroid hormone (PTH) and the serum concentrations of all three are directly correlated with each other. Vitamin D supplementation increases serum 25-OH D, which is converted into calcitriol. The latter, in turn, has an impact on both serum calcium (increases) and PTH levels (decrease), both of

Conclusion

The relationship between vitamin D and lipids in humans is a topic that has not been adequately investigated and trustworthy evidence does not yet exist. In spite the fact that some of the mechanisms by which vitamin D may decrease serum cholesterol have been proven in mice after molecular analyses, doubts still remain about their applicability to humans.

Despite the beneficial properties of high serum vitamin D concentrations in terms of the lipid profile shown in the observational studies,

Conflict of interest statement

The authors report no relationships that could be construed as a conflict of interest.

References (67)

  • M. Mizobuchi et al.

    Myocardial effects of VDR activators in renal failure

    J Steroid Biochem Mol Biol

    (2010)
  • L.M. Meems et al.

    The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload

    J Steroid Biochem Mol Biol

    (2012)
  • M.D. Witham et al.

    Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK – a randomised controlled trial

    Atherosclerosis

    (2013)
  • M.D. Witham et al.

    Effects of vitamin D supplementation on markers of vascular function after myocardial infarction – a randomised controlled trial

    Int J Cardiol

    (2013)
  • J.C. Zhou et al.

    Serum 25(OH)D and lipid levels in Chinese obese and normal weight males before and after oral vitamin D supplementation

    Biomed Environ Sci

    (2013)
  • W. Chai et al.

    Effects of calcium and vitamin D supplementation on blood pressure and serum lipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial

    Ann Epidemiol

    (2013)
  • A. Zittermann et al.

    Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers

    Am J Clin Nutr

    (2009)
  • Y.F. Yiu et al.

    Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes

    Atherosclerosis

    (2013)
  • R. Jorde et al.

    Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids

    Prog Lipid Res

    (2011)
  • H. Wang et al.

    Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials

    Lipids Health Dis

    (2012)
  • K.M. Huffman et al.

    Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in studies of a targeted risk reduction intervention through defined exercise I

    Am Heart J

    (2012)
  • I.R. Reid et al.

    Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial

    Am J Med

    (2002)
  • Y.C. Ku et al.

    Relationship between vitamin D deficiency and cardiovascular disease

    World J Cardiol

    (2013)
  • K.E. Poole et al.

    Reduced vitamin D in acute stroke

    Stroke

    (2006)
  • R. Scragg et al.

    Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study

    Int J Epidemiol

    (1990)
  • P. Messa et al.

    Vitamin D and the cardiovascular system: an overview of the recent literature

    Am J Cardiovasc Drugs

    (2013)
  • G. Bjelakovic et al.

    Vitamin D supplementation for prevention of mortality in adults

    Cochrane Database Syst Rev

    (2011)
  • T.J. Wang et al.

    Vitamin D deficiency and risk of cardiovascular disease

    Circulation

    (2008)
  • G. Kojima et al.

    Low dietary vitamin D predicts 34-year incident stroke: the Honolulu heart program

    Stroke

    (2012)
  • M.S. Hutchinson et al.

    Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study

    Eur J Endocrinol

    (2010)
  • P. Autier et al.

    Vitamin D supplementation and total mortality

    Arch Intern Med

    (2007)
  • J.R. Chaudhuri et al.

    Deficiency of 25-hydroxyvitamin d and dyslipidemia in Indian subjects

    J Lipids

    (2013)
  • P. Karhapää et al.

    Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias

    J Intern Med

    (2010)
  • Cited by (0)

    View full text